SUBSCRIBE
SUBSCRIBE
News   Drug Development

Apthera, Inc.'s Breast Cancer Vaccine NeuVax May Reduce Risk Of Death

April 14, 2008 | 
1 min read

SAN DIEGO (Reuters) - A small trial of an experimental vaccine designed to trigger the immune system to fight breast cancer suggests that it may reduce the risk of death for most patients, U.S. military researchers said on Sunday.

Clinical research Phase III
MORE ON THIS TOPIC
Close-Up Of Syringe With Bottles Against Blue Background
Vaccines
CDC Highlights Efficacy of COVID-19 Shots in Kids Amid FDA Probe of Alleged Deaths
December 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand holds a cut-out puzzle piece shaped like a human brain, backlit by sunlight against a bright yellow background, symbolizing creativity and problem-solving.
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
December 11, 2025
 · 
1 min read
 · 
Annalee Armstrong
Dartboard with three darts in the bullseyes. 3D illustration
Obesity
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
December 11, 2025
 · 
3 min read
 · 
Annalee Armstrong
Pictured: Entrance to Pfizer's office in Belgium
Breast cancer
Pfizer Builds Case for Tukysa as ‘New Standard Regimen’ in First-Line Metastatic Breast Cancer
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac